MYD88 mutations areslightly more frequent in marginal zone lymphoma (MZL) than CLL, but one of these two patients also harbored an SF3B1 mutation, which is far more frequent in CLL (Table S2). The gene discussed is SF3B1; the disease is marginal zone lymphoma.